Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04162756 |
|---|---|
| Brief Title: | Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies (ZUMA-18) |
| First Submitted : | November 11, 2019 |
| First Submitted that Met QC Criteria : | November 11, 2019 |
| First Posted : | November 14, 2019 |
| Last Update Submitted that Met QC Criteria : | October 6, 2021 |
| Last Update Posted : | October 14, 2021 |